135 related articles for article (PubMed ID: 37975398)
1. The value of serum lipoprotein-associated phospholipase A2, ischemia-modified albumin, and cystatin C in predicting coronary heart disease risk: a single center retrospective cohort study.
Le QF; Liu J; Chen L
Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10730-10735. PubMed ID: 37975398
[TBL] [Abstract][Full Text] [Related]
2. Serum IMA and LP-PLA2 Levels in Patients with Coronary Heart Disease and Their Correlation with the Degree of Myocardial Ischaemia and Their Diagnostic Value.
Zhang L; Li Z; Li N
Emerg Med Int; 2022; 2022():1698315. PubMed ID: 35726302
[TBL] [Abstract][Full Text] [Related]
3. Association between serum lipoprotein-associated phospholipase A2, ischemic modified albumin and acute coronary syndrome: a cross-sectional study.
Yang F; Ma L; Zhang L; Wang Y; Zhao C; Zhu W; Liang W; Liu Q
Heart Vessels; 2019 Oct; 34(10):1608-1614. PubMed ID: 30963302
[TBL] [Abstract][Full Text] [Related]
4. The expression and prognostic value of ischemia modified albumin (IMA), red blood cell distribution width (RDW), and lipoprotein (LP) in patients with diabetes mellitus complicated with coronary heart disease.
Xiang L; Zhang M; Wu H; Xie D
Ann Palliat Med; 2021 Apr; 10(4):4463-4471. PubMed ID: 33894715
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease.
Wu L; Shao P; Gao Z; Zhang S; Ma J; Bai J; Wei Y
Medicine (Baltimore); 2023 Nov; 102(46):e35982. PubMed ID: 37986337
[TBL] [Abstract][Full Text] [Related]
6. Correlation of Serum CysC, IMA, and LP-PLA2 Levels With Type 2 Diabetes Mellitus Patients With Lower Extremity Atherosclerotic Occlusive Disease.
Feng F; Chen Y; Wang G; Huang P; Zhu Q; Zhou B
Front Surg; 2022; 9():846470. PubMed ID: 35356504
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Effect of Lipoprotein-Associated Phospholipase A2 with Classical Risk Factors on Coronary Heart Disease: A Multi-Ethnic Study in China.
Ge PC; Chen ZH; Pan RY; Ding XQ; Liu JY; Jia QW; Liu Z; He SZ; An FH; Li LH; Li ZY; Gu Y; Zhu TB; Li CJ; Wang LS; Ma WZ; Yang ZJ; Jia EZ
Cell Physiol Biochem; 2016; 40(5):953-968. PubMed ID: 27941334
[TBL] [Abstract][Full Text] [Related]
8. Change of Inflammatory Factors in Patients with Acute Coronary Syndrome.
Ma CY; Xu ZY; Wang SP; Peng HY; Liu F; Liu JH; Ren FX
Chin Med J (Engl); 2018 Jun; 131(12):1444-1449. PubMed ID: 29893361
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of Serum Lipoprotein-Associated Phospholipase A2 for Type 2 Diabetes Mellitus Complicated with Metabolic Syndrome in Elderly Patients.
Ren J; Chang M; Song S; Zhao R; Xing X; Chang X
Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975498
[TBL] [Abstract][Full Text] [Related]
10. Changes in lipoprotein-Associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study.
White HD; Simes J; Stewart RA; Blankenberg S; Barnes EH; Marschner IC; Thompson P; West M; Zeller T; Colquhoun DM; Nestel P; Keech AC; Sullivan DR; Hunt D; Tonkin A;
J Am Heart Assoc; 2013 Oct; 2(5):e000360. PubMed ID: 24152981
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein-Associated Phospholipase A2 in Cardiac Disease: a Potential Early Biomarker of Unstable Coronary Artery Disease.
Li J; Zhou Z; Niu X; Li H
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390386
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Heiss G; Sharrett AR
Circulation; 2004 Feb; 109(7):837-42. PubMed ID: 14757686
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein-associated phospholipase A2 and risks of coronary heart disease and ischemic stroke in the general population: A systematic review and meta-analysis.
Li D; Wei W; Ran X; Yu J; Li H; Zhao L; Zeng H; Cao Y; Zeng Z; Wan Z
Clin Chim Acta; 2017 Aug; 471():38-45. PubMed ID: 28514697
[TBL] [Abstract][Full Text] [Related]
14. Association between Lp-PLA2 and coronary heart disease in Chinese patients.
Yang L; Liu Y; Wang S; Liu T; Cong H
J Int Med Res; 2017 Feb; 45(1):159-169. PubMed ID: 28222638
[TBL] [Abstract][Full Text] [Related]
15. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow.
Ding YD; Pei YQ; Wang R; Yang JX; Zhao YX; Liu XL; Shen H; Ma Q; Zhang S; Ge HL
BMC Cardiovasc Disord; 2020 May; 20(1):248. PubMed ID: 32460702
[TBL] [Abstract][Full Text] [Related]
16. PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.
Casas JP; Ninio E; Panayiotou A; Palmen J; Cooper JA; Ricketts SL; Sofat R; Nicolaides AN; Corsetti JP; Fowkes FG; Tzoulaki I; Kumari M; Brunner EJ; Kivimaki M; Marmot MG; Hoffmann MM; Winkler K; März W; Ye S; Stirnadel HA; Boekholdt SM; Khaw KT; Humphries SE; Sandhu MS; Hingorani AD; Talmud PJ
Circulation; 2010 Jun; 121(21):2284-93. PubMed ID: 20479152
[TBL] [Abstract][Full Text] [Related]
17. [Serum lipoprotein-associated phospholipase A2 level is positively correlated with the recurrence risk of acute ischemic cerebral infarction in hypertensive patients].
Liang L; Chen J; Zhang C; Wang Y; Luo B; Zhou T; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2023 Feb; 43(2):317-322. PubMed ID: 36946054
[TBL] [Abstract][Full Text] [Related]
18. The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study.
Liu X; Zhou W; Fan W; Li A; Pang J; Chen Z; Li X; Hu X; Zeng Y; Tang L
BMC Cardiovasc Disord; 2022 Apr; 22(1):177. PubMed ID: 35430800
[TBL] [Abstract][Full Text] [Related]
19. Performance Characteristics and Clinical Value of the Lipoprotein-Associated Phospholipase A2 by an Enzymatic Kinetic Method.
Lu M; Lv L
Lab Med; 2019 Jul; 50(3):273-278. PubMed ID: 30770710
[TBL] [Abstract][Full Text] [Related]
20. Study on the correlation between the concentration of plasma lipoprotein-associated phospholipase A2 and coronary heart disease.
Cen JM; Cheng J; Xiong QY; Mei BQ; Cai WB; Yang XL
Chronic Dis Transl Med; 2015 Jun; 1(2):105-109. PubMed ID: 29062994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
